Takeda inviting banks to join $31B Shire loan deal — 3 insights

Takeda Pharmaceuticals invited banks in Japan and internationally to participate in the syndication process for Takeda’s $30.85 billion loan as it prepares to purchase Shire, Bloomberg reports.

Advertisement

Here’s what you should know.

1. The syndication allows lenders an opportunity to lend money to Takeda for the Shire purchase.

2. Bloomberg reports investing is not without risk, as Takeda had its debt rating downgraded to A2 by Moody’s Investors Service earlier this month.

3. Unnamed sources report Takeda is asking lenders to commit to at least $500 million to join in the syndication.

More articles on supply chain:
7 things for ASC leaders to know for Thursday — May 24, 2018
Ransomware attacks surge in healthcare; surgical groups & orthopedic partners impersonated — 6 report findings
3 strategies for improving patient safety in ASCs

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply chain

Advertisement

Comments are closed.